Novasenta
Curated by SignalDeveloper of a drug discovery platform for cancer therapies
Overview
Developer of a drug discovery platform for cancer therapies. The company has developed a proprietary computational platform for single-cell RNA-based analysis of high-quality, human tumor samples. The company’s pipeline includes three programs representing the next generation of immuno-oncology targets and drug candidates.
Key facts
- Founded
- 2018
- Headquarters
- Pittsburgh, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view